These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37459965)
61. Preferential transfer of certain plasma membrane proteins onto T and B cells by trogocytosis. Daubeuf S; Aucher A; Bordier C; Salles A; Serre L; Gaibelet G; Faye JC; Favre G; Joly E; Hudrisier D PLoS One; 2010 Jan; 5(1):e8716. PubMed ID: 20090930 [TBL] [Abstract][Full Text] [Related]
62. Antigen-independent acquisition of MHC class II molecules by human T lymphocytes. Undale AH; van den Elsen PJ; Celis E Int Immunol; 2004 Oct; 16(10):1523-33. PubMed ID: 15351785 [TBL] [Abstract][Full Text] [Related]
63. A simple trogocytosis-based method to detect, quantify, characterize and purify antigen-specific live lymphocytes by flow cytometry, via their capture of membrane fragments from antigen-presenting cells. Daubeuf S; Puaux AL; Joly E; Hudrisier D Nat Protoc; 2006; 1(6):2536-42. PubMed ID: 17406507 [TBL] [Abstract][Full Text] [Related]
64. Peptide-specific intercellular transfer of MHC class II to CD4+ T cells directly from the immunological synapse upon cellular dissociation. Wetzel SA; McKeithan TW; Parker DC J Immunol; 2005 Jan; 174(1):80-9. PubMed ID: 15611230 [TBL] [Abstract][Full Text] [Related]
65. Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity. Li KJ; Wu CH; Lu CH; Shen CY; Kuo YM; Tsai CY; Hsieh SC; Yu CL Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668117 [TBL] [Abstract][Full Text] [Related]
66. Association of MHC class II-peptide complexes with plasma membrane lipid microdomains. Poloso NJ; Roche PA Curr Opin Immunol; 2004 Feb; 16(1):103-7. PubMed ID: 14734117 [TBL] [Abstract][Full Text] [Related]
68. Both APRIL and antibody-fragment-based CAR T cells for myeloma induce BCMA downmodulation by trogocytosis and internalization. Camviel N; Wolf B; Croce G; Gfeller D; Zoete V; Arber C J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36323436 [TBL] [Abstract][Full Text] [Related]
69. Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy. Werter IM; Schneiders FL; Scotet E; Verheul HM; de Gruijl TD; van der Vliet HJ Oncoimmunology; 2014 Oct; 3(9):e955343. PubMed ID: 25941612 [TBL] [Abstract][Full Text] [Related]
70. Antigen receptors on Thy-1+ CD3- CS-initiating cell. In vitro desensitization with hapten-amino acid or hapten-Ficoll conjugates, versus hapten-protein conjugates, suggests different antigen receptors on the immune cells that mediate the early and late components of murine contact sensitivity. Garssen J; Van Loveren H; Kato K; Askenase PW J Immunol; 1994 Jul; 153(1):32-44. PubMed ID: 7911496 [TBL] [Abstract][Full Text] [Related]
71. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Jiang H; Chess L Annu Rev Immunol; 2000; 18():185-216. PubMed ID: 10837057 [TBL] [Abstract][Full Text] [Related]
72. Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells. Furuta K; Ishido S; Roche PA Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19380-5. PubMed ID: 23129633 [TBL] [Abstract][Full Text] [Related]
73. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes. Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420 [TBL] [Abstract][Full Text] [Related]
74. A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells. Xiang J; Huang H; Liu Y J Immunol; 2005 Jun; 174(12):7497-505. PubMed ID: 15944248 [TBL] [Abstract][Full Text] [Related]
75. Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity. Denkberg G; Cohen CJ; Lev A; Chames P; Hoogenboom HR; Reiter Y Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9421-6. PubMed ID: 12093904 [TBL] [Abstract][Full Text] [Related]
76. Co-receptors and recognition of self at the immunological synapse. Gascoigne NR; Zal T; Yachi PP; Hoerter JA Curr Top Microbiol Immunol; 2010; 340():171-89. PubMed ID: 19960314 [TBL] [Abstract][Full Text] [Related]
77. Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab. Tischer-Zimmermann S; Bonifacius A; Santamorena MM; Mausberg P; Stoll S; Döring M; Kalinke U; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B Front Immunol; 2023; 14():878953. PubMed ID: 37033971 [TBL] [Abstract][Full Text] [Related]
78. Despite disorganized synapse structure, Th2 cells maintain directional delivery of CD40L to antigen-presenting B cells. Gardell JL; Parker DC PLoS One; 2017; 12(10):e0186573. PubMed ID: 29023539 [TBL] [Abstract][Full Text] [Related]
79. Syk tyrosine kinase and B cell antigen receptor (BCR) immunoglobulin-alpha subunit determine BCR-mediated major histocompatibility complex class II-restricted antigen presentation. Lankar D; Briken V; Adler K; Weiser P; Cassard S; Blank U; Viguier M; Bonnerot C J Exp Med; 1998 Sep; 188(5):819-31. PubMed ID: 9730884 [TBL] [Abstract][Full Text] [Related]
80. The Major Histocompatibility Complex Class II-CD4 Immunologic Synapse in Alcoholic Hepatitis and Autoimmune Liver Pathology: The Role of Aberrant Major Histocompatibility Complex Class II in Hepatocytes. Lu JG; Ji P; French SW Am J Pathol; 2020 Jan; 190(1):25-32. PubMed ID: 31669415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]